VF
AXDX

Virtu Financial’s Accelerate Diagnostics AXDX Stock Holding History

Virtu Financial’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,214
Closed -$13K – 1357
2024
Q4 		$13K Buy
+11,214
New +$18.6K ﹤0.01% 1355
2024
Q3 		– Sell
-10,389
Closed -$12K – 1361
2024
Q2 		$12K Buy
+10,389
New +$10.9K ﹤0.01% 1105
2023
Q1 		– Sell
-3,577
Closed -$25K – 1525
2022
Q4 		$25K Buy
3,577
+1,746
+95% +$19.1K ﹤0.01% 1215
2022
Q3 		$28K Buy
+1,831
New +$30.3K ﹤0.01% 1333
2021
Q1 		– Sell
-1,124
Closed -$85K – 1589
2020
Q4 		$85K Buy
+1,124
New +$101K 0.01% 1104
2020
Q3 		– Sell
-1,046
Closed -$159K – 1049
2020
Q2 		$159K Buy
+1,046
New +$103K 0.02% 775

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial's AXDX Position: Q1 2025 in Review

Virtu Financial sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 11,214 shares — an estimated $13K sold.

Virtu Financial first reported a position in AXDX in Q2 2020 and held it in 6 quarters. The position peaked at $159K in Q2 2020. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.

  • Virtu Financial reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 11,214 Accelerate Diagnostics shares in Q1 2025, an estimated $13K.
  • Virtu Financial first reported a position in Accelerate Diagnostics in Q2 2020 and held it in 6 quarters.
  • Virtu Financial's Accelerate Diagnostics position peaked at $159K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.